Connecticut Leads Coalition Lawsuit Alleging Multibillion-Dollar Drug Price Fixing Scheme
Connecticut is leading a coalition of 51 states and territories that have filed another lawsuit against generic drug manufacturers. They allege the drug makers are defrauding American consumers.
Connecticut Attorney General William Tong says the manufacturers perpetrated a multi-billion fraud against the American public by inflating prices and reducing competition for topical drugs used to treat a variety of skin conditions.
“Generic drugs and prescription drugs. That’s why you see 51 states and attorneys general joining together and taking this aggressive action.”
He says documents and phone records obtained in the coalition’s investigation of the industry show that 25 corporations and 10 individuals were involved in the price fixing.
“This evidence is shocking and damning in places. And we are taking strong action and using every tool at our disposal to hold wrongdoers accountable.”
The lawsuit was filed in federal court in Connecticut. It seeks damages, civil penalties and actions by the court to restore competition to the U.S. generic drug market.